PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Trial details
- Registry ID
- NCT06157151
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical CancerNCT06157151 | PGEN | Phase 2 | Recruiting | 2026-11-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |